Literature DB >> 3578411

Prognostic factors and operative treatment of stages IB to IIB cervical cancer.

E Burghardt, H Pickel, J Haas, M Lahousen.   

Abstract

Between 1971 and 1985, a total of 325 cases of cervical cancer, Stages IB to IIB, in which operation was performed were evaluated with a view toward prognostic factors and survival rates. In radical abdominal operations, a complete resection of parametrial tissue was the goal. Extensive lymphadenectomy of the pelvis was performed. Operative specimens were processed by giant sections comprising cervix, lateral parametria, and vaginal cuff. Lymph nodes were cut by step-serial sections. Exact measurements of tumor sizes were done along with investigations of parametrium and lymph nodes. Tumors were classified according to a ratio of tumor size to size of cervix. Incidence of lymph node involvement increased with tumor size, reaching a maximum of 68.3% in the group with a ratio from 70% to 80%. Direct spread into the parametrium was rarely found, even in larger tumors occupying the entire cervix. parametrial lymph nodes were most often involved; these were scattered over the entire ligament. Five-year survival rates reached 88.1% in patients with no nodal involvement and 60.9% with nodal involvement. In the latter, the results depended on the number of nodal groups involved and the diameter of metastases. Parametrial involvement alone had no influence on healing rates, but when pelvic nodes were simultaneously involved, the results were less satisfactory. Survival rates based on tumor size differed only between the group with a ratio up to 20% and the large-tumor groups, with rates ranging from 97.5% to 70.9%. There was no statistical difference between Stages IB (31.1% positive nodes) and IIB (44.1% positive nodes) with regard to survival rates (82.2% and 76.9%, respectively).

Entities:  

Mesh:

Year:  1987        PMID: 3578411     DOI: 10.1016/0002-9378(87)90374-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer.

Authors:  Keiichiro Nakamura; Ikuo Joja; Junichi Kodama; Atsushi Hongo; Yuji Hiramatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-10       Impact factor: 9.236

2.  Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.

Authors:  Masayoshi Hosaka; Hidemichi Watari; Takashi Mitamura; Yousuke Konno; Tetsuji Odagiri; Tatsuya Kato; Mahito Takeda; Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2010-09-15       Impact factor: 3.402

3.  Urological complications after radical hysterectomy with or without radiotherapy for cervical cancer.

Authors:  G Ralph; K Tamussino; W Lichtenegger
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

4.  Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy.

Authors:  Junko Haraga; Keiichiro Nakamura; Chiaki Omichi; Takeshi Nishida; Tomoko Haruma; Tomoyuki Kusumoto; Noriko Seki; Hisashi Masuyama; Norihisa Katayama; Susumu Kanazawa; Yuji Hiramatsu
Journal:  Mol Clin Oncol       Date:  2016-09-21

5.  An evaluation of chemotherapy in patients with cancer of the cervix and lymph node metastases.

Authors:  H T Ng; C C Yuan; Y Y Kan; E S Ho; M S Yen; K C Chao
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

6.  Histological grading and DNA content as predictors of distant metastases in squamous cell carcinoma of the uterine cervix.

Authors:  M Anton; R Nenutil; J Zaloudík
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

7.  Urodynamics following radical abdominal hysterectomy for cervical cancer.

Authors:  G Ralph; K Tamussino; W Lichtenegger
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

8.  Clinical significance of mucin production in post-irradiated cervical carcinoma.

Authors:  N Y Cheung; R J Collins; H Y Ngan; L C Wong; H K Ma
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

9.  The posttreatment mean apparent diffusion coefficient of primary tumor is superior to pretreatment ADCmean of primary tumor as a predictor of prognosis with cervical cancer.

Authors:  Keiichiro Nakamura; Satoshi Kajitani; Ikuo Joja; Tomoko Haruma; Chikako Fukushima; Tomoyuki Kusumoto; Noriko Seki; Yuji Hiramatsu
Journal:  Cancer Med       Date:  2013-06-16       Impact factor: 4.452

10.  Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods.

Authors:  Bogdan Obrzut; Maciej Kusy; Andrzej Semczuk; Marzanna Obrzut; Jacek Kluska
Journal:  BMC Cancer       Date:  2017-12-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.